Data shows iberdomide combination therapy delivers progression free survival and safety in relapsed and refractory multiple ...
DUBLIN--(BUSINESS WIRE)-- ICON plc (ICLR), (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback